Market Overview

'Don't Give Up On Biotech Yet,' Says This CFA


G. Thomas Lackey was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick.

CFA and Barber Lackey Financial Group Chief Investment Officer Thomas Lackey said that investors should not "give up on biotech.”

Lackey did not worry about what large companies were doing in the sector as the industry was really about new things and the “companies that are really doing groundbreaking stuff.”

As a result, focusing on the large biotech names might not be the best way to play the industry’s advances in Lackey’s view.

Lackey mentioned SPDR S&P Biotech (ETF) (NYSE: XBI) and iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) as ways to gain exposure to biotech.

iShares NASDAQ Biotechnology Index (ETF) recently traded at $363.45, up 0.82 percent.

SPDR S&P Biotech (ETF) recently traded at $234.74, up 1.58 percent.

Listen to the show here:

Posted-In: Lackey Financial Group Thomas LackeyBiotech Exclusives Trading Ideas Interview General


Related Articles (XBI + IBB)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

Technical Expert Watching Wendys, Home Depot

Baird Sees 'Deteriorating' Risk/Reward Balance For Regional Banks